QuellTX
Mahsa Nemani has a range of research and laboratory experience in the biotechnology and life sciences industry. Their most recent position was as a Research Associate - Translational at Quell Therapeutics starting in November 2022. Prior to that, they worked as a Research Associate at Synexa Life Sciences from April to November 2022.
In 2021, Mahsa worked as a Research Technician at Imperial College London from January to April. Mahsa also gained experience as a Laboratory Technician at UK Biocentre from May to December 2020.
In addition, Mahsa worked as a Research Assistant at King's College London from January to July 2020. Overall, their work experience demonstrates a strong background in research and laboratory techniques within the biotechnology and life sciences field.
Mahsa Nemani obtained a Bachelor of Science degree from Brunel University London between 2015 and 2018. The specific field of study during that time is not provided. Later, in 2019 and 2020, Mahsa attended King's College London, where they pursued a Master of Science degree in Immunology.
This person is not in the org chart
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.